PD1-PDL1-IN 1 (TFA)

• UNSPSC Description:

  PD1-PDL1-IN 1 TFA (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 TFA is useful as immune modulator[1].

• Target Antigen:

  PD-1/PD-L1

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/pd1-pdl1-in-1-tfa.html

• Purity:

  95.11

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  C[C@@H](O)[C@@H](C(O)=O)NC(N[C@H](C1=NC(N2CCNCC2)=NO1)CC(N)=O)=O.O=C(O)C(F)(F)F

• Molecular Weight:

  499.40

• References & Citations:

  [1]Pottayil Govindan Nair Sasikumar , et al. 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators. WO2016142886A2.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light)

• Clinical Information:

  No Development Reported